#marstacimab

Live, measured metrics for the hashtag #marstacimab from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #marstacimab

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$10.85/ year · 11-character #name
Claim #marstacimab$10.85/yrBuy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
1
Recent posts
Mastodon
Recent pace
Mastodon · last 1
0
Avg reactions / post
Mastodon · last 1
Reddit posts / month
Reddit search
Open-web mentions
hashtag.org Firehose

Day-by-day usage

measured · fosstodon.org (Mastodon public tags API) · fetched 2026-08-03 07:48 UTC
0
07-28
0
07-29
0
07-30
0
07-31
0
08-01
0
08-02
0
08-03

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · fosstodon.org (Mastodon public search API) · fetched 2026-08-03 07:48 UTC

No related tags with measured usage found for #marstacimab.

Live pulse

measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-08-03 07:48 UTC

Everything below is measured over the latest 1 public posts.

Posting hours (UTC)

00:0012:0023:00

Languages: English (1)

Avg boosts / post: 0

Top of the latest posts

  • Hympavzi (marstacimab): New Treatment for Hemophilia On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval........... #bleedingdisorder #HemophiaB

    Scientific European@[email protected]002024-10-12 18:49 UTCView post →

What “marstacimab” means

Wikipedia

Marstacimab, sold under the brand name Hympavzi, is a monoclonal antibody medication used for the treatment of hemophilia A and hemophilia B. It is a tissue factor pathway inhibitor antagonist. It was developed by Pfizer. Marstacimab is a new type of medication that, rather than replacing a clotting factor, works by reducing the amount, and therefore, the activity of, the naturally occurring anticoagulation protein called tissue factor pathway inhibitor. This increases the amount of thrombin, an

Marstacimab” on Wikipedia (CC BY-SA) →

#marstacimab across platforms

every network with a public tag surface

Follow #marstacimab straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/marstacimab